Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have been given a consensus rating of “Hold” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $60.67.

Several research analysts have issued reports on the company. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. Zacks Investment Research lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Pivotal Research restated a “buy” rating and issued a $80.00 target price (up from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Finally, Bank of America Corporation raised their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research note on Monday, July 10th.

WARNING: This report was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/10/11/nu-skin-enterprises-inc-nus-receives-60-67-average-target-price-from-analysts.html.

Nu Skin Enterprises (NUS) traded down 0.59% during trading on Friday, hitting $62.80. 581,104 shares of the stock traded hands. Nu Skin Enterprises has a one year low of $46.35 and a one year high of $65.98. The stock has a market cap of $3.32 billion, a PE ratio of 21.00 and a beta of 1.40. The company has a 50-day moving average price of $61.31 and a 200 day moving average price of $59.16.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The firm had revenue of $550.10 million during the quarter, compared to analyst estimates of $548.09 million. During the same period in the prior year, the company posted $0.79 earnings per share. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. Analysts expect that Nu Skin Enterprises will post $3.23 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th were paid a $0.36 dividend. The ex-dividend date of this dividend was Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.29%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 48.81%.

In related news, General Counsel D Matthew Dorny sold 7,500 shares of the firm’s stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $60.88, for a total value of $456,600.00. Following the transaction, the general counsel now owns 52,230 shares in the company, valued at $3,179,762.40. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Ryan S. Napierski sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total value of $520,000.00. Following the completion of the transaction, the president now owns 68,170 shares in the company, valued at approximately $4,431,050. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,107 shares of company stock valued at $1,264,445. 5.20% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of NUS. UBS Asset Management Americas Inc. boosted its holdings in Nu Skin Enterprises by 2.8% in the first quarter. UBS Asset Management Americas Inc. now owns 36,402 shares of the company’s stock valued at $2,022,000 after acquiring an additional 1,004 shares during the last quarter. Sei Investments Co. boosted its holdings in Nu Skin Enterprises by 129.6% in the first quarter. Sei Investments Co. now owns 27,334 shares of the company’s stock valued at $1,518,000 after acquiring an additional 15,430 shares during the last quarter. Prudential Financial Inc. boosted its holdings in Nu Skin Enterprises by 460.4% in the first quarter. Prudential Financial Inc. now owns 42,879 shares of the company’s stock valued at $2,381,000 after acquiring an additional 35,227 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Nu Skin Enterprises by 11.2% in the first quarter. SG Americas Securities LLC now owns 15,251 shares of the company’s stock valued at $847,000 after acquiring an additional 1,538 shares during the last quarter. Finally, Victory Capital Management Inc. bought a new position in Nu Skin Enterprises in the first quarter valued at about $472,000. Institutional investors and hedge funds own 79.25% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.